[Hematologic and endocrinologic effects of pulsatile cardiopulmonary bypass using a centrifugal pump]
- PMID: 1634838
[Hematologic and endocrinologic effects of pulsatile cardiopulmonary bypass using a centrifugal pump]
Abstract
The effects of pulsatile and nonpulsatile flow during cardiopulmonary bypass (CPB) with of centrifugal pump (Sarns) and membrane oxygenator, on blood cells, hemodynamics, and hormonal response were studied. In the pulsatile group (group P) in which pulsatile flow was generated by centrifugal pump and a 20 Fr arterial cannula was used, hemolysis and reduction of platelet count during CPB were more marked than in the nonpulsatile group (group NP), in which the same type of circuit was used. When the 20 Fr arterial cannula was replaced with a 24 Fr cannula (group Pc), the rate of hemolysis during CPB was significantly reduced compared with that in group P (p less than 0.05). The rate of rise in plasma free hemoglobin from 10 to 70 minutes CPB in group Pc was 15.0 mg/dl/hr, this value did not exceed that in either group NP or in group Pr, in which a roller pump rather than centrifugal pump was used to generate pulsatile flow. These findings show that pulsatile CPB with a centrifugal pump produces no deleterious hematologic effect in clinical use. The rise in the level of angiotensin II in group P was significantly smaller than that in group NP (p less than 0.05), and the rise in plasma renin activity and levels of angiotensin I, adrenalin and noradrenaline were smaller than those in group NP, although these differences were no significance. These findings indicate that the centrifugal pump generates pulsatile flow effectively, although not so effectively as to prevent the rise in peripheral vascular resistance. During CPB, there was no change in levels of thyroid hormones, including free T3, free T4 and reverse T3, in either pulsatile groups P and Pc or nonpulsatile group. TSH level in group Pc was significantly elevated in contrast with that in the nonpulsatile group (p less than 0.05), in which no change in TSH level was seen. It is suggested that pulsatile perfusion using a centrifugal pump might maintain sufficient hypothalamic-pituitary function to permit secretion of TSH in response to various stimuli.
Similar articles
-
Clinical effectiveness of centrifugal pump to produce pulsatile flow during cardiopulmonary bypass in patients undergoing cardiac surgery.Artif Organs. 2011 Feb;35(2):E18-26. doi: 10.1111/j.1525-1594.2010.01152.x. Epub 2011 Feb 14. Artif Organs. 2011. PMID: 21314839 Clinical Trial.
-
A pulsatile cardiopulmonary bypass system that prevents negative pressure at the membrane oxygenator.ASAIO J. 1993 Oct-Dec;39(4):936-41. ASAIO J. 1993. PMID: 8123931
-
Pulsatile compared with nonpulsatile perfusion using a centrifugal pump for cardiopulmonary bypass during coronary artery bypass grafting. Effects on systemic haemodynamics, oxygenation, and inflammatory response parameters.Perfusion. 1995;10(1):3-12. doi: 10.1177/026765919501000102. Perfusion. 1995. PMID: 7795311 Clinical Trial.
-
Quantification of pressure-flow waveforms and selection of components for the pulsatile extracorporeal circuit.J Extra Corpor Technol. 2009 Mar;41(1):P20-5. J Extra Corpor Technol. 2009. PMID: 19361036 Free PMC article. Review.
-
Benefits of pulsatile flow in pediatric cardiopulmonary bypass procedures: from conception to conduction.Perfusion. 2011 Sep;26 Suppl 1:35-9. doi: 10.1177/0267659111404468. Perfusion. 2011. PMID: 21933820 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous